FDA
-
-
-
-
-
-
-
Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Prime Medicine (PRME) Unveils Strategically Focused Pipeline
-
-
-
-
-
-
-
Prime Medicine (PRME) announces fda clearance of investigational new drug (ind) application for pm359 for the treatment of chronic granulomatous disease
-
-
-
-
-
323,908 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

